News

MoonLake Immunotherapeutics remains a promising clinical-stage biotech, with potentially its first FDA approval in 2026.
Twenty-five travelers on a Delta Air Lines flight en route from Salt Lake City to Amsterdam sustained injuries from turbulence that caused the flight to divert to Minneapolis-St. Paul ...
Zeta Global Holdings Corp. (NYSE:ZETA) joins our list of 10 stocks with huge catalysts on the horizon. The company unveils next-gen AI marketing tools, sets bold 2028 financial targets ahead of Q2 ...
Salt Lake City's mayor is calling for a review of conditions at every property the city owns following a brush fire that destroyed two apartment buildings in Millcreek.
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to persistent weakness in demand for the blockbuster human papillomavirus vaccine ...
A change in full-year guidance by management wasn't particularly welcome.
Merck posted lower Q2 earnings as vaccine sales dropped, but oncology and animal health segments saw strong growth; 2025 guidance slightly raised.
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by the end of 2027.
Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...
Merck will execute $3 billion in cost cuts to support the launches of more than 20 products nearing the market, the company announced Tuesday. The reductions will be spread across administrative, ...